Active	Status	Sponsor type	Region	Phase	Filter
16 Active 8 Inactive 24 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Ji Yao
NCT03363763: Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex	Terminated	2	24	US, RoW	Sirolimus 0.2%, Rapamune, rapamycin, mTOR inhibitor, Sirolimus 0.4%, Placebo ointment, Placebo	Aucta Pharmaceuticals, Inc	Angiofibroma of Face, Tuberous Sclerosis	03/23	03/23
Tian, Xin
NCT04652297: Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers	Not yet recruiting	1	76	RoW	HS-10356, Placebo	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Healthy	08/21	08/21
Wang, Luwen
No trials found
Wang, Xingling
No trials found
Xu, Falin
No trials found
Guan, Yichun
No trials found
Ren, Chenchen
No trials found
Li, Hezhou
No trials found
Hu, Yaofei
No trials found
Ban, Yanjie
No trials found